Drug
Bapineuzumab
Bapineuzumab: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| bapineuzumab NCT00397891 | Phase 1 | Alzheimer Disease |
Latest
No recent events.
Follow Bapineuzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.